The resolution is expected to help elevate NTDs within global and national policy agendas, strengthen accountability, reinforce the links between health and human rights, and mobilise greater political will and resources to accelerate progress towards elimination.
Geoff Warne, CEO of the International Federation of Anti-Leprosy Associations (ILEP) shared:
“ILEP welcomes this decision by the UN Human Rights Council and appreciates the advocacy of ILEP member Anesvad and others that were active in bringing about this result. The severe stigmatisation experienced by people with lived experience of leprosy (Hansen’s disease) is well documented, but it’s a known fact that several of the other NTDs - especially those affecting the skin and those with disabling consequences - are also associated with discriminatory attitudes and denial of human rights. ILEP echoes the call on States to take firm action to end stigma and discrimination related to all NTDs, and looks forward to OHCHR’s report on the matter.”
Jimmy Innes, Lepra UK CEO echoes Geoff’s sentiments, reiterating that the recognition of human rights issues surrounding NTDs such as leprosy and lymphatic filariasis, will in time, help to reduce systemic discrimination and remove barriers to improve access to diagnostic and treatment services for some of the world’s most vulnerable people.
For more information read here.
